China Pharmaceuticals & Healthcare Key Analysis

Tuberculosis Burden Remains High

While prevalence rates can provide much insight on the extent of a disease in a country, the data can be very patchy - particularly in developing countries that do not have the resources to record...

Read article ›
Asia Pacific Remains Highly Attractive

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a market, whether...

Read article ›

Filter results

By Geography

By Sector

By Information Type